Literature DB >> 182944

Studies in a phenotypic female with 17-alpha-hydroxylase deficiency.

A K Kershnar, D Borut, M D Kogut, E G Biglieri, M Schambelan.   

Abstract

In a 19-year-old phenotypic female (46, XY) with hypertension and hypokalemia, studies confirmed 17-alpha-hydroxylase deficiency. Prior to diagnosis she had been considered to have testicular feminization. Increased plasma progesterone and urinary pregnanediol levels were present before treatment. Increased secretion rates of deoxycorticosterone and corticosterone and abnormally low production of cortisol and aldosterone were present. Following treatment with hydrocortisone, plasma progesterone, serum potassium, and urinary pregnanediol levels and DOC and B secretions were normal. Aldosterone secretion six months after treatment remained low. Normal blood pressure measurements were achieved during treatment with hydrocortisone and oral estrogen with the patient at rest; however, mild elevations in blood pressure (130/90 mm Hg) have been noted despite continued hydrocortisone therapy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182944     DOI: 10.1016/s0022-3476(76)80535-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  17-alpha-hydroxylase deficiency in three siblings: short- and long-term studies.

Authors:  C Scaroni; A Biason; G Carpenè; G Opocher; F Mantero
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

2.  Male pseudohermaphroditism due to 17-hydroxylase deficiency.

Authors:  A D'Alberton; E Reschini; T Motta; A Catania
Journal:  J Endocrinol Invest       Date:  1989-03       Impact factor: 4.256

3.  17 alpha-Hydroxylase deficiency with persistence of müllerian ducts in a genotypic male and paradoxical aldosterone secretion.

Authors:  N S Panesar; V T Yeung; J C Chan; C C Shek; M G Nicholls; C S Cockram
Journal:  Postgrad Med J       Date:  1993-02       Impact factor: 2.401

Review 4.  XY females with enzyme deficiencies of steroid metabolism. A brief review.

Authors:  K Madan; J Schoemaker
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

Review 5.  Adrenocortical hypertension.

Authors:  Angelo Capricchione; Nathaniel Winer; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

6.  Adrenocortical hypertension.

Authors:  Angelo Capricchione; Nathaniel Winer; James R Sowers
Journal:  Curr Urol Rep       Date:  2006-01       Impact factor: 2.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.